Clasificación en acciones
#35164
Gamida Cell Ltd. operates as a clinical-stage biopharmaceutical firm, dedicated... Gamida Cell Ltd. operates as a clinical-stage biopharmaceutical firm, dedicated to pioneering cell therapies aimed at eradicating blood cancers and other severe hematological conditions. The company's leading investigational product, omidubicel—a specialized cell therapy—has successfully concluded its Phase III clinical evaluation for individuals afflicted with high-risk hematologic malignancies. Furthermore, it is currently undergoing Phase I/II trials for patients suffering from severe aplastic anemia. Another significant therapeutic candidate, GDA-201, an immunotherapy harnessing natural killer cells, is progressing through Phase I/II studies to address relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. Beyond these, Gamida Cell is actively advancing a broader natural killer (NK) cell pipeline, which includes GDA-301, GDA-401, GDA-501, and GDA-601, with the ambition of treating both hematologic cancers and solid tumors. Founded in 1998, the company maintains its corporate headquarters in Jerusalem, Israel.
Precio por acción
$0.0327
Última sincronización: 2025-06-17
Capitalización bursátil
$4.34M
Comercio Gamida Cell Ltd. (GMDA)
Precio GMDA con Capital del mercado a B
Capitalización de mercado de Gamida Cell Ltd.(GMDA)
Capitalización bursátil: $4.34M
A fecha de August 2026, Gamida Cell Ltd. tiene una capitalización de mercado de $4.34M. Esto convierte a Gamida Cell Ltd. en la 35164th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de Gamida Cell Ltd. desde 2018 hasta 2026
GMDA en comparación con los más populares 5 títulos stocks
| Precio por GMDA |
|
Activo B |
Capital del mercado en B |
Resultados |
|
|
|
|
$5.452T
|
+125,692,588.97%
|
|
|
|
|
$4.490T
|
+103,517,214.83%
|
|
|
|
|
$4.162T
|
+95,964,100.96%
|
|
|
|
|
$3.676T
|
+84,757,892.92%
|
|
|
|
|
$2.833T
|
+65,315,634.53%
|
